Structure-activity relationships of first bishydroxymethyl-substituted cage dimeric 4-aryl-1,4-dihydropyridines as HIV-1 protease inhibitors

By Hilgeroth A.   Lilie H.  

European Journal of Medicinal Chemistry, Vol. 38, Iss. 5, 2003-05 ,pp. : 495-499

Elsevier

Access to resources Recommend Favorite

Dimeric 4-Aryl-1,4-Dihydropyridines: Development of a Third Class of Nonpeptidic HIV-1 Protease Inhibitors

By  

Mini Reviews in Medicinal Chemistry, Vol. 2, Iss. 3, 2002-06 ,pp. : 235-245

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesis and in vitro evaluation of 1,8-diazaanthraquinones bearing 3-dialkylaminomethyl or 3-(N-alkyl- or N-aryl)carbamoyloxymethyl substituent

By Lee H.   Lee S.-I.   Cho J.   Choi S.U.   Yang S.-I.  

European Journal of Medicinal Chemistry, Vol. 38, Iss. 7, 2003-07 ,pp. : 695-702

Elsevier

Access to resources Recommend Favorite

Interactions of the Dimeric Triad of HIV-1 Aspartyl Protease with Inhibitors

By MAGER PETER   DE CLERCQ ERIK   FROEYEN MATHEUS   REINHARDT ROBERT  

Drug Design and Discovery, Vol. 18, Iss. 2-3, 2003-04 ,pp. : 53-64

Taylor & Francis Ltd

Access to resources Recommend Favorite

Synthesis and Biological Evaluation of N-(Alkyl)-2-Thiophen-2-Ylacetamides Series As A New Class of Antitubercular Agents

By  

Letters in Drug Design & Discovery, Vol. 5, Iss. 3, 2008-04 ,pp. : 221-224

Bentham Science Publishers

Access to resources Recommend Favorite